NEW DELHI: The Co-founder and Joint Managing Director of Hyderabad-based Bharat Biotech, Suchitra Ella has said that vaccines should not be a barrier to enter into any nation.

NEW DELHI: After Brazil announced suspending a $324 million Covaxin contract that has mired President Jair Bolsonaro in accusations of irregularities, Bharat Biotech has said it has not received any advance payments nor supplied any vaccines.

NEW DELHI: The supply price of Covaxin to the government of India at Rs 150 a dose is a non-competitive price and clearly not sustainable in the long run. Hence a higher price in private markets is required to offset part of the costs, Bharat Biotech said on Tuesday.

HYDERABAD: Bharat Biotech, makers of India's first indigenous vaccine for Covid-19, has advised people not to take 'Covaxin' if they have allergies, fever, bleeding disorder, are on blood thinners, immune-compromised, or are on medicines that affect immune system.

NEW DELHI: A meeting of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) is currently underway to discuss the permission sought by vaccine developer Bharat Biotech to conduct clinical trials of its intranasal vaccine for the coronavirus.

NEW DELHI: Domestic airlines on Wednesday provided the logistical support to pharma major Bharat Biotech for shipping out anti-Covid-19 'Covaxin' vaccines to 11 cities.

NEW DELHI: After the alleged death of a volunteer enrolled in Bharat Biotech's Covaxin clinical trial in Bhopal, the Hyderabad-based company clarified on Saturday that the death was unrelated to the vaccine and the probable cause of death was cardio respiratory failure as a result of suspected poisoning.

NEW DELHI: Days after getting Drugs Controller General of India's (DCGI) nod for India's first indigenously-made coronavirus vaccine, Bharat Biotech has again knocked on the doors of the drug controller seeking permission to conduct clinical trials of their intranasal vaccine for the viral disease.

NEW DELHI: Hyderabad-based vaccine manufacturer Bharat Biotech has concluded the recruitment of volunteers for the phase III trials of its Covid vaccine, Covaxin, on Thursday after achieving the sample size it had promised to the ethics committee. The firm has achieved the targeted number of volunteers, which is 25,800 participants, in total.

NEW DELHI: In a show of solidarity after some bitter comments, Adar Poonawala and Krishna Ella, jointly on behalf of Serum Institute and Bharat Biotech, on Tuesday communicated their combined intent to develop manufacture and supply the Covid-19 vaccines for India and globally.

NEW DELHI: Hyderabad-based Bharat Biotech said on Monday that its vaccine is efficient against the mutant strain of novel coronavirus found in the UK while announcing that its data would be made public within a week.

NEW DELHI: After the latest decision to approve the vaccine by AstraZeneca and Oxford University as well as by Bharat Biotech for emergency use in India to immunise people against the COVID-19 virus; many experts have questioned the foundation of these approvals and reasons why other candidates such as Sputnik V and Pfizer were neglected in the process.

NEW DELHI: The Central Licensing Authority on Sunday granted permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution, after the indigenous coronavirus vaccine received regulatory approval for emergency use.

NEW DELHI: The Central Government on Saturday said that the expert panel of India's drug regulator has recommended granting permission for restricted emergency use of the indigenously developed Covid-19 vaccine 'Covaxin' in "public interest as an abundant precaution."

NEW DELHI: The Subject Expert Committee of the Central Drug Standard Control Organisation on Friday has held that the data provided by Bharat Biotech for its coronavirus vaccine 'Covaxin' is not sufficient for grant of emergency use approval and has asked for more information, top sources said.

AMARAVATI: Former Andhra Pradesh Chief Minister and Telugu Desam Party (TDP) president N. Chandrababu Naidu on Saturday hailed Prime Minister Narendra Modi's visit to Bharat Biotech as a strong motivation and recalled that Genome Valley in Hyderabad was his brainchild.

 HYDERABAD:  Prime Minister Narendra Modi will be visiting vaccine maker Bharat Biotech's facility here on Saturday as part of his three-city tour to take stock of the Covid-19 vaccine development work in the country.

 HYDERABAD: Leading vaccine maker Bharat Biotech on Wednesday announced a licensing agreement with Washington University School of Medicine in St. Louis for a novel chimp-adenovirus, single dose intranasal vaccine for Covid-19.

HYDERABAD: Telangana Chief Minister K. Chandrashekhar Rao on Wednesday said his government was ensuring that Telangana, as the home state, gets priority in supply of Covid-19 vaccine as and when it is manufactured by Hyderabad-based Bharat Biotech.